Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California; Division of Cardiology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California.
J Card Fail. 2021 May;27(5):560-567. doi: 10.1016/j.cardfail.2021.01.020.
Patients admitted with cardiogenic shock (CS) have high mortality rates, readmission rates, and healthcare costs. Palliative care services (PCS) may be underused, and the association with 30-day readmission and other predictive factors is unknown. We studied the frequency, etiologies, and predictors of 30-day readmission in CS admissions with and without PCS in the United States.
Using the 2017 Nationwide Readmissions Database, we identified admissions for (1) CS, (2) CS with PCS, and (3) CS without PCS. We compared differences in outcomes and predictors of readmission using multivariable logistic regression analysis accounting for survey design. Of 133,738 CS admissions nationally in 2017, 36.3% died inpatient. Among those who survived, 8.6% used PCS and 21% were readmitted within 30 days. Difference between CS with and without PCS groups included mortality (72.8% vs 27%), readmission rate (11.6% vs 21.9%), most frequent discharge destination (50.2% skilled nursing facilities vs 36.4% home), hospitalization cost per patient ($51,083 ± $2,629 vs $66,815 ± $1,729). The primary readmission diagnoses for both groups were heart failure (32.1% vs 24.4%). PCS use was associated with lower rates of readmission (odds ratio, 0.462; 95% confidence interval, 0.408-0.524; P < .001). Do-not-resuscitate status, private pay, self-pay, and cardiac arrest were negative predictors, and multiple comorbidities was a positive predictor of readmission.
The use of PCS in CS admissions remains low at 8.6% in 2017. PCS use was associated with lower 30-day readmission rates and hospitalization costs. PCS are associated with a decrease in future acute care service use for critically ill cardiac patients but underused for high-risk cardiac patients.
患有心源性休克(CS)的患者死亡率、再入院率和医疗保健费用都很高。姑息治疗服务(PCS)可能未得到充分利用,其与 30 天再入院和其他预测因素的关联尚不清楚。我们研究了美国 CS 入院患者中使用和未使用 PCS 的 30 天再入院的频率、病因和预测因素。
使用 2017 年全国再入院数据库,我们确定了(1)CS、(2)CS 伴 PCS 和(3)CS 不伴 PCS 的入院患者。我们使用多变量逻辑回归分析比较了再入院结果和预测因素的差异,该分析考虑了调查设计。2017 年全国共有 133738 例 CS 入院患者,其中 36.3%住院期间死亡。在存活的患者中,8.6%使用了 PCS,21%在 30 天内再次入院。CS 伴 PCS 组与无 PCS 组的差异包括死亡率(72.8%比 27%)、再入院率(11.6%比 21.9%)、最常见的出院去向(50.2%康复护理机构比 36.4%家庭)、每位患者的住院费用(51083 美元±2629 美元比 66815 美元±1729 美元)。两组的主要再入院诊断均为心力衰竭(32.1%比 24.4%)。PCS 的使用与较低的再入院率相关(比值比,0.462;95%置信区间,0.408-0.524;P<0.001)。不复苏状态、私人支付、自付和心搏骤停是负预测因素,多种合并症是再入院的正预测因素。
2017 年,PCS 在 CS 入院患者中的使用率仍较低,为 8.6%。PCS 的使用与 30 天再入院率和住院费用的降低相关。PCS 与危重心脏病患者未来急性护理服务使用的减少相关,但对高危心脏病患者的使用不足。